In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow the link below for further details.
Delivering mitochondrial health
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow the link below for further details. |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
1 event,
Abliva will attend the CNS Summit 2024, taking place November 10-13 at Encore Boston Harbor. The company's CEO, Ellen Donnelly, has organized and will join the spotlight panel discussion: Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session, on November 11, at 1:00 p.m. ET, featuring representatives from Stealth-, Tisento- and Saol Therapeutics. Follow […] |
1 event, |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
In mid-November, Abliva will attend LSX's Investival Showcase in London, UK. Abliva's CEO, Ellen Donnelly, will be presenting the company at 11:30 a.m. GMT. The Investival Showcase is a Biotech, Healthtech, and Medtech Networking & Pitching Event. Follow the link below for more details. |
1 event,
In late November, Abliva will participate in BioStock's Life Science Summit in Lund, Sweden. CMO, Magnus Hansson, will be presenting the company at 15:10 CET on November 21. For more details on the event, follow the link below. |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|